OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
Yingzi Zhang, Yan Yang, Yiran Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Yingzi Zhang, Yan Yang, Yiran Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Showing 22 citing articles:
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Ubiquitin-specific proteases: From biological functions to potential therapeutic applications in gastric cancer
Kaiqiang Li, Xiao Bai, Ang-Ting Ke, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116323-116323
Open Access | Times Cited: 8
Kaiqiang Li, Xiao Bai, Ang-Ting Ke, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116323-116323
Open Access | Times Cited: 8
Prognostic value of peripheral blood neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, pan-immune-inflammation value and systemic immune-inflammation index for the efficacy of immunotherapy in patients with advanced gastric cancer
Maodong Fu, Xiuping Zhang, Feng Shen, et al.
Immunotherapy (2024) Vol. 16, Iss. 8, pp. 551-563
Closed Access | Times Cited: 8
Maodong Fu, Xiuping Zhang, Feng Shen, et al.
Immunotherapy (2024) Vol. 16, Iss. 8, pp. 551-563
Closed Access | Times Cited: 8
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Research progress on the immune microenvironment and immunotherapy in gastric cancer
Pei Mou, Qing-hua Ge, Rong Sheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Pei Mou, Qing-hua Ge, Rong Sheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review
Peifeng Chen, Zhangming Chen, Wannian Sui, et al.
Biological Research (2025) Vol. 58, Iss. 1
Open Access
Peifeng Chen, Zhangming Chen, Wannian Sui, et al.
Biological Research (2025) Vol. 58, Iss. 1
Open Access
Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer
Xiangyang He, Xin‐Yuan Guan, Yan Li
Frontiers in Immunology (2025) Vol. 16
Open Access
Xiangyang He, Xin‐Yuan Guan, Yan Li
Frontiers in Immunology (2025) Vol. 16
Open Access
4D Biofabrication of Magnetically Augmented Callus Assembloid Implants Enables Rapid Endochondral Ossification via Activation of Mechanosensitive Pathways
Konstantinos Ioannidis, Andreas Dimopoulos, Isaak Decoene, et al.
Advanced Science (2025)
Open Access
Konstantinos Ioannidis, Andreas Dimopoulos, Isaak Decoene, et al.
Advanced Science (2025)
Open Access
An antibody-dependent cellular phagocytosis-related gene signature predicts survival and response to immunotherapy in stomach adenocarcinoma
Xiaochuan Li, Hongjian Wang, Xiaofeng Li, et al.
Medicine (2025) Vol. 104, Iss. 14, pp. e42079-e42079
Open Access
Xiaochuan Li, Hongjian Wang, Xiaofeng Li, et al.
Medicine (2025) Vol. 104, Iss. 14, pp. e42079-e42079
Open Access
Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study
Xinyan Wang, Xiaoling Liu, Huwei Dai, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Xinyan Wang, Xiaoling Liu, Huwei Dai, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer
Kuo Kang, Xuanxuan Li, Yuanhao Peng, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3165-3165
Open Access | Times Cited: 7
Kuo Kang, Xuanxuan Li, Yuanhao Peng, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3165-3165
Open Access | Times Cited: 7
A Systematic Exploration of Key Candidate Genes and Pathways in the Biogenesis of Human Gastric Cancer: A Comprehensive Bioinformatics Investigation
Shuhylul Hannan, Ithmam Hami, Rajib Kumar Dey, et al.
Journal of Translational Gastroenterology (2024) Vol. 2, Iss. 1, pp. 9-20
Open Access | Times Cited: 2
Shuhylul Hannan, Ithmam Hami, Rajib Kumar Dey, et al.
Journal of Translational Gastroenterology (2024) Vol. 2, Iss. 1, pp. 9-20
Open Access | Times Cited: 2
Prognostic analysis of related factors of adverse reactions to immunotherapy in advanced gastric cancer and establishment of a nomogram model
Xu-Xu He, Bang Du, Tao Wu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1268-1280
Open Access | Times Cited: 2
Xu-Xu He, Bang Du, Tao Wu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1268-1280
Open Access | Times Cited: 2
Clinicopathological characteristics and prognosis of Epstein-Barr virus–associated gastric cancer
Linlin Li, Ao-yang Yu, Mei Chun Zhu, et al.
Archives of Virology (2024) Vol. 169, Iss. 5
Closed Access | Times Cited: 2
Linlin Li, Ao-yang Yu, Mei Chun Zhu, et al.
Archives of Virology (2024) Vol. 169, Iss. 5
Closed Access | Times Cited: 2
Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions
Guo-Ming Chen, Dongqiang Luo, Xiangjun Qi, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Guo-Ming Chen, Dongqiang Luo, Xiangjun Qi, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Immune-mediated hepatitis: Basic concepts and treatment
J.A. Velarde-Ruiz Velasco, Diana Karen Tapia Calderón, Sergio Cerpa‐Cruz, et al.
Revista de Gastroenterología de México (English Edition) (2024) Vol. 89, Iss. 1, pp. 106-120
Open Access | Times Cited: 1
J.A. Velarde-Ruiz Velasco, Diana Karen Tapia Calderón, Sergio Cerpa‐Cruz, et al.
Revista de Gastroenterología de México (English Edition) (2024) Vol. 89, Iss. 1, pp. 106-120
Open Access | Times Cited: 1
Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer
Qi Zhang, Chenying Yang, Zhijian Ma, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 8, pp. 1611-1620
Closed Access | Times Cited: 1
Qi Zhang, Chenying Yang, Zhijian Ma, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 8, pp. 1611-1620
Closed Access | Times Cited: 1
Comprehensive analysis of anoikis-related genes in prognosis and immune infiltration of gastric cancer based on bulk and single-cell RNA sequencing data
Xiaobo Yang, Zheng Zhu, Tianyu Liang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 13163-13173
Closed Access | Times Cited: 2
Xiaobo Yang, Zheng Zhu, Tianyu Liang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 13163-13173
Closed Access | Times Cited: 2
Hepatitis inmunomediada: conceptos básicos y tratamiento
J.A. Velarde-Ruiz Velasco, Diana Karen Tapia Calderón, Sergio Cerpa‐Cruz, et al.
Revista de Gastroenterología de México (2024) Vol. 89, Iss. 1, pp. 106-120
Open Access
J.A. Velarde-Ruiz Velasco, Diana Karen Tapia Calderón, Sergio Cerpa‐Cruz, et al.
Revista de Gastroenterología de México (2024) Vol. 89, Iss. 1, pp. 106-120
Open Access
Immune Biomarkers and Predictive Signatures in Gastric Cancer: Optimizing Immunotherapy Responses
Sundaram Vickram, Shofia Saghya Infant, S. Manikandan, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155743-155743
Closed Access
Sundaram Vickram, Shofia Saghya Infant, S. Manikandan, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155743-155743
Closed Access
Research Progress of Immune Checkpoint Inhibitors in the Treatment of Advanced Gastric Cancer
静如 王
Advances in Clinical Medicine (2023) Vol. 13, Iss. 10, pp. 16191-16197
Closed Access
静如 王
Advances in Clinical Medicine (2023) Vol. 13, Iss. 10, pp. 16191-16197
Closed Access
Nomograms for stratified prognosis prediction of gastric cancer by integrating programmed death ligand 1 and tumor-infiltrating immune cells
Xiumin Qi, Yixuan Guo, Jiayi Wan, et al.
Research Square (Research Square) (2023)
Open Access
Xiumin Qi, Yixuan Guo, Jiayi Wan, et al.
Research Square (Research Square) (2023)
Open Access
Prognostic Significance of Programmed Cell Death Ligand 1 Expression in High-Grade Serous Ovarian Carcinoma: A Systematic Review and Meta-Analysis
Jeongwan Kang, Kang Min Han, Hera Jung, et al.
Diagnostics (2023) Vol. 13, Iss. 20, pp. 3258-3258
Open Access
Jeongwan Kang, Kang Min Han, Hera Jung, et al.
Diagnostics (2023) Vol. 13, Iss. 20, pp. 3258-3258
Open Access
